Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP427926.RA34rb7uSc8sxYElxyAYD6khlB5B8YyKEz4E27dlJlnRM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP427926.RA34rb7uSc8sxYElxyAYD6khlB5B8YyKEz4E27dlJlnRM130_assertion type Assertion NP427926.RA34rb7uSc8sxYElxyAYD6khlB5B8YyKEz4E27dlJlnRM130_head.
- NP427926.RA34rb7uSc8sxYElxyAYD6khlB5B8YyKEz4E27dlJlnRM130_assertion description "[IGRP inhibitors may be an attractive new approach for the treatment of insulin secretion defects in type 2 diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP427926.RA34rb7uSc8sxYElxyAYD6khlB5B8YyKEz4E27dlJlnRM130_provenance.
- NP427926.RA34rb7uSc8sxYElxyAYD6khlB5B8YyKEz4E27dlJlnRM130_assertion evidence source_evidence_literature NP427926.RA34rb7uSc8sxYElxyAYD6khlB5B8YyKEz4E27dlJlnRM130_provenance.
- NP427926.RA34rb7uSc8sxYElxyAYD6khlB5B8YyKEz4E27dlJlnRM130_assertion SIO_000772 14722102 NP427926.RA34rb7uSc8sxYElxyAYD6khlB5B8YyKEz4E27dlJlnRM130_provenance.
- NP427926.RA34rb7uSc8sxYElxyAYD6khlB5B8YyKEz4E27dlJlnRM130_assertion wasDerivedFrom befree-2016 NP427926.RA34rb7uSc8sxYElxyAYD6khlB5B8YyKEz4E27dlJlnRM130_provenance.
- NP427926.RA34rb7uSc8sxYElxyAYD6khlB5B8YyKEz4E27dlJlnRM130_assertion wasGeneratedBy ECO_0000203 NP427926.RA34rb7uSc8sxYElxyAYD6khlB5B8YyKEz4E27dlJlnRM130_provenance.